Skip to main content
. 2011 Nov 18;54(3):414–423. doi: 10.1093/cid/cir799

Figure 2.

Figure 2.

Effect of fosamprenavir-ritonavir on plasma concentrations of buprenorphine (A), norbuprenorphine (B), buprenorphine-3-glucuronide (C), and norbuprenorphine-3-glucuronide (D).